| Heterotransplantation of human breast carcinomas in nude mice. Correlation between successful heterotransplants, poor prognosis and amplification of the HER-2/neu oncogene. | breast, |
| Chromogenic in situ hybridization for Her-2/neu-oncogene in breast cancer: comparison of a new dual-colour chromogenic in situ hybridization with immunohistochemistry and fluorescence in situ hybridization. | breast, |
| data suggest that Stat3 might be a useful therapeutic target in breast tumors showing amplification and/or overexpression of the ErbB-2 oncogene, which normally display aggressive, metastatic behavior | breast, |
| Nuclear expression of KLF6 tumor suppressor factor is highly associated with overexpression of ERBB2 oncoprotein in ductal breast carcinomas. | breast, |
| [Expression of HER-2/neu oncogene in hepatocellular carcinoma and the clinical implications]. | liver, |
| TGF-beta1 and C-erb-B2 neu oncoprotein in Egyptian HCV related chronic liver disease and hepatocellular carcinoma patients. | liver, |
| Evaluation of tumor markers (HER-2/neu oncoprotein, CEA, and CA 15.3) in patients with locoregional breast cancer: prognostic value. | breast, |
| Prognostic significance of immunohistochemical expression of EGFR and C-erbB-2 oncoprotein in curatively resected gastric cancer. | gastric, |
| Evaluation of HER2/neu oncoprotein in serum and tissue samples of women with breast cancer: correlation with clinicopathological parameters. | breast, |
| Survivin regulation by HER2 through NF-kappaB and c-myc in irradiated breast cancer cells. | breast, |
| Insights into biological processes that come under the control of HER-2 after it acquires full oncogenic potential in a breast cancer cell line. | breast, |
| Targeted Therapy in Metastatic Breast Cancer: The HER2/neu Oncogene. | breast, |
| Increasing CD44+/CD24(-) tumor stem cells, and upregulation of COX-2 and HDAC6, as major functions of HER2 in breast tumorigenesis. | breast, |
| Aberrant expression of the human epidermal growth factor receptor 2 oncogene is not a common feature in osteosarcoma. | osteosarcoma, |
| Expression status of the autophagy-regulatory gene ATG6/BECN1 in ERBB2-positive breast carcinomas: bypassing ERBB2-induced oncogenic senescence to regulate the efficacy of ERBB2-targeted therapies. | breast, |
| HER-2 oncogene amplification and overall survival of breast carcinoma patients. | breast, |
| Expression of the invasive phenotype by MCF-7 human breast cancer cells transfected to overexpress protein kinase C-alpha or the erbB2 proto-oncogene. | breast, |
| The neu-oncogene protein as a predictive factor for haematogenous metastases in breast cancer patients. | breast, |
| Activating point mutations of the Neu oncogene in schwannomas induced by ethylnitrosourea exposure to day-15 and day-18 fetal rats. | schwannomas, |
| Expression of her-2/neu oncogene in breast-cancer - correlation of quantitative immunocytochemistry and prognostic factors. | breast, |